Sun Pharmaceutical has acquired Chattem Chemicals, US-based drug ingredients manufacturer for an undisclosed amount. Sun Pharma informed in a filing to the Bombay Stock Exchange that the American subsidiary of the company has bought Chattem Chemicals from Elcat Inc,.However, the financial details of the transaction were kept undisclosed. The acquisition is subject to clearance from regulatory authorities, the filing added.
This is Sun Pharma''s third acquisition in the US. In 2005, the company had acquired a facility in Hungary that manufactures controlled substance active pharmaceutical ingredients (APIs). The same year it had acquired a manufacturing site in New Jersey. Chattem is a registered narcotic raw material importer with the US Drug Enforcement Administration and manufactures a variety of active pharmaceutical ingredients.
This is Sun Pharma''s third acquisition in the US. In 2005, the company had acquired a facility in Hungary that manufactures controlled substance active pharmaceutical ingredients (APIs). The same year it had acquired a manufacturing site in New Jersey. Chattem is a registered narcotic raw material importer with the US Drug Enforcement Administration and manufactures a variety of active pharmaceutical ingredients.
No comments:
Post a Comment